9 METERS BIOPHARMA, INC. Quarterly Debt-to-equity in % from Q2 2021 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
9 Meters Biopharma, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q1 2023.
  • 9 Meters Biopharma, Inc. Debt-to-equity for the quarter ending March 31, 2023 was 267 %, a 1450% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 267 +250 +1450% Mar 31, 2023
Q4 2022 112 +96.3 +612% Dec 31, 2022
Q3 2022 50.9 +35.2 +224% Sep 30, 2022
Q2 2022 23.4 -0.06 -0.26% Jun 30, 2022
Q1 2022 17.2 Mar 31, 2022
Q4 2021 15.7 Dec 31, 2021
Q3 2021 15.7 Sep 30, 2021
Q2 2021 23.5 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.